$NVDA stock rose 4% this week, according to our price data from Polygon.
It has been the most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $NVDA (you can track the company live on Quiver's $NVDA stock page):
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 140 times in the past 6 months. Of those trades, 0 have been purchases and 140 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- AJAY K PURI (EVP, Worldwide Field Ops) has made 0 purchases and 9 sales selling 1,000,000 shares for an estimated $183,002,962.
- MARK A STEVENS has made 0 purchases and 4 sales selling 794,182 shares for an estimated $142,193,969.
- DEBORA SHOQUIST (EVP, Operations) has made 0 purchases and 20 sales selling 309,840 shares for an estimated $56,186,171.
- HARVEY C JONES sold 250,000 shares for an estimated $44,333,450
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 84 sales selling 208,430 shares for an estimated $37,132,313.
- DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 16 sales selling 109,986 shares for an estimated $20,556,412.
- AARTI S. SHAH has made 0 purchases and 3 sales selling 19,000 shares for an estimated $3,357,549.
- A BROOKE SEAWELL sold 12,728 shares for an estimated $2,341,117
- JOHN DABIRI has made 0 purchases and 2 sales selling 3,630 shares for an estimated $667,756.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NVDA Hedge Fund Activity
We have seen 2,892 institutional investors add shares of $NVDA stock to their portfolio, and 2,592 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP removed 125,140,953 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $21,389,091,686
- CARDANO RISK MANAGEMENT B.V. removed 70,049,522 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $11,972,864,300
- VANGUARD GROUP INC added 43,149,475 shares (+1.9%) to their portfolio in Q4 2025, for an estimated $8,047,377,087
- SG AMERICAS SECURITIES, LLC removed 37,810,007 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,462,486,396
- JPMORGAN CHASE & CO removed 32,478,144 shares (-6.6%) from their portfolio in Q4 2025, for an estimated $6,057,173,856
- SOFTBANK GROUP CORP. removed 32,110,456 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,988,600,044
- FMR LLC added 22,789,685 shares (+2.3%) to their portfolio in Q1 2026, for an estimated $3,895,212,960
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 22 times in the past 6 months. Of those trades, 9 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOHN MCGUIRE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/15, 01/30 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 7 times. They made 3 purchases worth up to $80,000 on 03/13, 01/30, 11/18 and 4 sales worth up to $95,000 on 04/14, 03/25, 12/24, 12/19.
- REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.
- REPRESENTATIVE DANIEL MEUSER has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 03/25, 02/25, 01/30, 01/14.
- REPRESENTATIVE TIM MOORE sold up to $50,000 on 03/24.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 03/19.
- REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 1 purchase worth up to $500,000 on 01/16 and 1 sale worth up to $5,000,000 on 12/24.
- SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/09.
- SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 11/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 21 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 03/31/2026
- Needham issued a "Buy" rating on 02/18/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
- Truist Securities issued a "Buy" rating on 12/29/2025
- Stifel issued a "Buy" rating on 12/29/2025
- Baird issued a "Outperform" rating on 12/26/2025
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 31 analysts offer price targets for $NVDA in the last 6 months, with a median target of $275.0.
Here are some recent targets:
- Joshua Buchalter from TD Cowen set a target price of $275.0 on 05/15/2026
- Timothy Arcuri from UBS set a target price of $275.0 on 05/14/2026
- Srini Pajjuri from RBC Capital set a target price of $250.0 on 05/14/2026
- C.J. Muse from Cantor Fitzgerald set a target price of $350.0 on 05/14/2026
- Aaron Rakers from Wells Fargo set a target price of $315.0 on 05/12/2026
- Cody Acree from Benchmark set a target price of $250.0 on 03/31/2026
- Kevin Cassidy from Rosenblatt set a target price of $325.0 on 03/23/2026
You can track data on $NVDA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
